Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone MC5L9Q) SynExpress C-Cy5-β-B Modified CD8+ T cells (CAT#: ITS-1224-CR275)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone MC5L9Q). We employs the AAV (CMV-Cy5-β-catenin-BamHI) vector components and the SynExpress system of the Single base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CCL2
Clone
MC5L9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
β-catenin
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.87
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.